Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Hadasit, the technology transfer company of Hadassah University Hospitals, and Ramot at Tel Aviv University, the technology transfer company of Tel Aviv University, have announced that the Lubo Cervical Collar, designed to help save lives in trauma situations, has demonstrated to be 100% effective in a preliminary efficacy study.
Subscribe to our email newsletter
The IRB approved study was registered with the National Institute of Health (NIH) and operated under the guidelines of both the NIH and the Israeli Ministry of Health.
Yuval Meroz, an anesthesiologist at Hadassah University Hospital and part of the clinical team of the LuboCollar study, said: “Ten generally healthy people, between the ages of 18 and 60, who were scheduled for fracture surgeries at Hadassah University Hospital, were enrolled in the efficacy study. Results showed that LuboCollar was 100% successful in securing the airways of the seven patients who lost muscle tone after receiving general anesthesia. To generate more safety data, LuboCollar was also employed during the surgeries of the three patients who were able to breathe independently after anesthesia. In all cases, no adverse side effects were reported. We are now waiting for approval from the Ministry of Health of Israel to extend enrollment numbers in order to further study the efficacy of the product.”